Ir Innovate Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-06-2024
- Paid Up Capital ₹ 0.10 M
as on 27-06-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 17.46%
(FY 2023)
- Profit 50.76%
(FY 2023)
- Ebitda 0.12%
(FY 2023)
- Net Worth 13.83%
(FY 2023)
- Total Assets 21.83%
(FY 2023)
About Ir Innovate Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madhur Saxena and Devesh Kumar serve as directors at the Company.
- CIN/LLPIN
U74120UP2014PTC066783
- Company No.
066783
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ir Innovate Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhur Saxena  | Director | 03-Nov-2014 | Current |
| Devesh Kumar | Director | 03-Nov-2014 | Current |
Financial Performance of Ir Innovate Research.
Ir Innovate Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.46% increase. The company also saw a substantial improvement in profitability, with a 50.76% increase in profit. The company's net worth Soared by an impressive increase of 13.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ir Innovate Research?
In 2023, Ir Innovate Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Crms Clinical Research Management Services Private LimitedActive 10 years 23 daysMadhur Saxena and Devesh Kumar are mutual person
- Cts Clinical Trial Services India Private LimitedActive 9 years 11 months
Devesh Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ir Innovate Research?
Ir Innovate Research has a workforce of 26 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ir Innovate Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ir Innovate Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
